Skip to content

Study · Non-randomized trial · 1990

3 results

Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency.

McGauley GA, Cuneo RC, Salomon F, Sönksen PH

Hormone research1 Jan 1990Cited by 113 (Europe PMC)

PMID2245968 (opens in a new tab)DOI10.1159/000181584 (opens in a new tab)PepBankPUB-02245968
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. 3 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In GH-deficient adults, preliminary analysis showed less perceived illness with GH than placebo after 6 months.

    In plain wordsIn GH-deficient adults, preliminary analysis showed less perceived illness with GH than placebo after 6 months.

    Peptide
    HGH (somatotropin)
    Outcome
    DecreasePerceived illness
    Study

    n: not reported in source

    Comparator
    Placebo
    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    Dose not stated · 6 monthsAs given in this study (human).

    Source sentences

    Summary
    Preliminary analysis of treatment results shows that after 6 months, those patients receiving active treatment experienced less perceived illness than the placebo group.
    2 context sentences
    Summary · context
    The effect of recombinant-DNA human growth hormone treatment on psychological well-being and quality of life was studied in adults with GH deficiency (GHD).
    Summary · context
    24 adults who satisfied strict criteria for GHD took part in a double-blind, placebo-controlled, 6-month trial.
  2. 02HumanNon-randomized trialEfficacy outcome

    In GH-deficient adults in a placebo-controlled trial of GH treatment, significant improvements were noted in perceived energy level.

    In plain wordsIn GH-deficient adults in a placebo-controlled GH trial, improvements in perceived energy level were noted.

    Peptide
    HGH (somatotropin)
    Outcome
    IncreasePerceived energy
    Study

    n: not reported in source

    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    Dose not stated · 6 monthsAs given in this study (human).

    Source sentences

    Summary
    Significant psychological improvements were noted in the patients' perception of their energy level and mood.
    3 context sentences
    Summary · context
    Preliminary analysis of treatment results shows that after 6 months, those patients receiving active treatment experienced less perceived illness than the placebo group.
    Summary · context
    The effect of recombinant-DNA human growth hormone treatment on psychological well-being and quality of life was studied in adults with GH deficiency (GHD).
    Summary · context
    24 adults who satisfied strict criteria for GHD took part in a double-blind, placebo-controlled, 6-month trial.
  3. 03HumanNon-randomized trialEfficacy outcome

    In GH-deficient adults in a placebo-controlled trial of GH treatment, significant improvements were noted in mood.

    In plain wordsIn GH-deficient adults in a placebo-controlled GH trial, improvements in mood were noted.

    Peptide
    HGH (somatotropin)
    Outcome
    IncreaseMood
    Study

    n: not reported in source

    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    Dose not stated · 6 monthsAs given in this study (human).

    Source sentences

    Summary
    Significant psychological improvements were noted in the patients' perception of their energy level and mood.
    3 context sentences
    Summary · context
    Preliminary analysis of treatment results shows that after 6 months, those patients receiving active treatment experienced less perceived illness than the placebo group.
    Summary · context
    The effect of recombinant-DNA human growth hormone treatment on psychological well-being and quality of life was studied in adults with GH deficiency (GHD).
    Summary · context
    24 adults who satisfied strict criteria for GHD took part in a double-blind, placebo-controlled, 6-month trial.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:37 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.